Form 4: CareDx Director Exercises Options Under 10b5-1 Plan
Insider Transaction Report
CareDx Director Michael Goldberg reported exercising stock options for 26,500 shares of common stock, effective March 31, 2026, under a pre-arranged trading plan.
Summary
- CareDx, Inc. Director Michael Goldberg filed a Form 4 reporting the exercise of stock options for a total of 26,500 shares of common stock.
- The transactions are scheduled to occur on March 31, 2026, and are made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
- The exercises involve three tranches of options: 5,255 shares at an exercise price of $5.02, 9,745 shares at $4.95, and 11,500 shares at $1.22.
- Following these transactions, Michael Goldberg's direct beneficial ownership of CareDx common stock will increase to 183,961 shares.
- The options exercised had vesting schedules starting in 2016 and 2017, with expiration dates ranging from June 2026 to July 2027.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral-to-slightly positive event. While routine for a director's compensation, the exercise of options, even if pre-planned and future-dated, generally reflects a director's continued ownership stake and alignment with shareholder interests.
Positives
- The exercise of options by a director, even if pre-planned, can signal continued confidence in the company's long-term prospects.
- The transactions are conducted under a Rule 10b5-1 plan, indicating a pre-scheduled, non-discretionary transaction designed to comply with insider trading rules.
Future Outlook
The filing reports future-dated transactions under a Rule 10b5-1 plan, indicating pre-scheduled insider activity rather than a forward-looking statement on company performance.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions and do not typically provide broader industry context. This filing reflects a director's individual compensation and investment strategy within CareDx, Inc., rather than a trend across the healthcare or diagnostics industry.
Comparison to Industry Standards
- Not applicable as this filing reports individual insider transactions, not company performance or project results that can be benchmarked against specific comparable companies or industry projects.
Related Party Transactions
- The reported transactions are insider dealings, as they involve a director of the company exercising stock options granted by the company.
Stakeholder Impact
- Shareholders: The director's increased ownership aligns their interests with other shareholders, potentially signaling confidence.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 07/16/2016 | Vesting start date for 5,255 shares subject to an option. |
| 08/01/2016 | Vesting start date for 9,745 shares subject to an option. |
| 08/13/2017 | Vesting start date for 11,500 shares subject to an option. |
| 03/31/2026 | Transaction date for the exercise of all reported stock options. |
| 04/01/2026 | Signature date of the Form 4 filing. |
| 06/16/2026 | Expiration date for the option to buy 5,255 shares. |
| 07/15/2026 | Expiration date for the option to buy 9,745 shares. |
| 07/13/2027 | Expiration date for the option to buy 11,500 shares. |
Keywords
CareDx, CDNA, Form 4, Insider Transaction, Stock Options, Director, 10b5-1 Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.